Search clinical trials for: conjugated estrogens/bazedoxifene (CE/BZA)

Total 153 results

Pfizer

Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Healthy

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Breast Cancer | Risk Reduction

United States
Carol Fabian, MD

Active, not recruiting

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Increased Risk for Development of Breast Cancer

United States
VA Office of Research and Development

Withdrawn

Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans (CE/BZA)

Obesity | Menopause | Prediabetes

United States
Tulane University Health Sciences Center

Completed

Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) (BIM)

Obesity | Glucose Homeostasis | Postmenopausal Symptoms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Endometrial Hyperplasia | Osteoporosis
Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Endometrial Hyperplasia | Osteoporosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

Menopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Vaginal Atrophy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/CE in Postmenopausal Women

Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Vasomotor Symptoms Associated With Menopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Healthy
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Completed

Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause" (Duavee)

Depression | Perimenopausal Disorder

United States
University of Kansas Medical Center
Pfizer

Completed

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Breast Cancer

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

Menopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women

Healthy

United States
University of Southern California
National Institute on Aging (NIA)

Recruiting

Advancing Postmenopausal Preventive Therapy (APPT)

Atherosclerosis | Cognitive Decline

United States
Carol Fabian, MD
Breast Cancer Research Foundation

Terminated

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

Focus of Study is Healthy Women at Risk for Breast Cancer

United States
Pfizer

Completed

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Menopause | Osteoporosis

United States, Colombia, Australia, Hungary, Poland, Finland, Argentina, Chile, Denmark, Mexico, New Zealand, Norway
Northwestern University
National Cancer Institute (NCI); Pfizer; University of California, San Francisco and other collaborators

Recruiting

The PROMISE Study: Duavee in Women With DCIS

Postmenopausal | Ductal Breast Carcinoma In Situ

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Osteoporosis | Postmenopause

China, Taiwan, Korea, Republic of
Pfizer

Completed

Study Evaluating Changes In Mammographic Breast Density

Osteoporosis

United States, Norway, Brazil, Netherlands
University of Oxford
National Institute for Health Research, United Kingdom; Oxford Clinical Trials...

Completed

Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis? (HOPE-e)

Hand Osteoarthritis

United Kingdom
TriHealth Inc.

Completed

The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

Pelvic Organ Prolapse | Vaginal Atrophy

United States
Laval University
V Joseph; C Minville; C Rheaume

Recruiting

Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea (Alpha MenoX)

Sleep Apnea | Oxidative Stress | Post Menopausal

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

Postmenopause
Loyola University

Completed

The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

Overactive Bladder

United States
Hospital de Clinicas de Porto Alegre

Unknown

Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women

Arthralgia

Brazil
University of Pennsylvania

Active, not recruiting

Intravenous Estrogen in Kidney Transplant Study (PERT)

Ischemia Reperfusion Injury

United States
University of Texas Southwestern Medical Center
American Urogynecologic Society Foundation Astellas Research Award

Completed

Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor (PET)

Pelvic Organ Prolapse | Menopause

United States
National Institute on Aging (NIA)

Completed

AFTER: Altering Fat Through Estrogen and Raloxifene

Postmenopause

United States
Medstar Health Research Institute
Pfizer

Terminated

Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH) (EVER)

Microscopic Hematuria

United States
Duramed Research

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

Menopause

United States
Universidade Federal do Paraná

Completed

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

Endometrial Hyperplasia | Pelvic Organ Prolapse | Vaginitis Atropic
Penn State University
The John B. Pierce Laboratory

Recruiting

Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee (Endo2/SA3)

Endometriosis

United States
Mayo Clinic

Completed

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

Urinary Tract Infections

United States
Duramed Research

Completed

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Nocturnal Vasomotor Symptoms

United States
University of California, San Diego
NYU Langone Health; American Urogynecologic Society

Completed

Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women (VESPR)

Recurrent Urinary Tract Infection

United States
The Cleveland Clinic
Pfizer

Unknown

Premarin Versus Toviaz for Treatment of Overactive Bladder

Overactive Bladder

United States
Duramed Research

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

Menopause

United States
Pfizer

Completed

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Osteoporosis

United States, Canada, France, Greece, Germany, Argentina, Chile, Croatia, South Africa, Belgium, Italy, Spain, Australia, Bulgaria, Hong Kong, Poland, Finland, Slovakia, Russian Federation, Brazil, Norway, New Zealand, Lithuania, Est... and more
The Alfred
Monash University; Monash Health

Recruiting

Bazedoxifene -Treatment for Women With Schizophrenia

Schizophrenia | Schizo Affective Disorder | Schizophreniform Disorders

Australia
Hyundai Pharmaceutical Co., LTD.

Completed

HDDO-1614 Intervention Trial

Osteoporosis

Korea, Republic of
Duramed Research

Completed

A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes

Hot Flashes

United States
Gynecologic Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...

Terminated

Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

Endometrial Cancer

United States
Hôpital Fribourgeois

Recruiting

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (BAZE)

Pancreas Cancer

Switzerland

Search clinical trials for: conjugated estrogens/bazedoxifene (CE/BZA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations